Aptamers to NCL (nucleolin) have been used for targeted delivery of siRNA chimeras for lung cancer therapy [118] and PET imaging in vivo in a xenograft lung adenocarcinoma model [119]. This evidence concerns the gene NUCLEOLIN and lung cancer.